LCA interim position statement on domperidone
Thursday, June 12, 2014
The LCA has issued an interim position statement on domperidone for providers until the London Cancer New Drugs Group produce a recommendation in the summer.
LCA recruiting patient and public representatives
Monday, June 09, 2014
Two patient and public representatives are needed to become members of the LCA Clinical Board.
Quality in Care oncology awards now open
Wednesday, May 21, 2014
The QiC oncology awards are now open, with five new categories for 2014.
Director of research and development appointed
Monday, May 19, 2014
The LCA has appointed Professor Stan Kaye as Director of Research and Development.
LCA Annual Report highlights progress in reducing variation
Monday, April 28, 2014
The LCA's Annual Report 2013/14 highlights the progress and achievements made over the past year in reducing variation in cancer services across west and south London.